The blood clot retrieval devices market would grow at a CAGR of 14.79% over the predicted time frame. The market is expected to increase in value from US$ 1.49 Bn in 2022 to US$ 4.5 Bn in 2030.
The on blood
clot retrieval devices Market, which provides a business strategy, research
& development activities, concise outline of the market valuation, valuable
insights pertaining to market share, size, supply chain analysis, competitive
landscape and regional proliferation of this industry.
Download
Free Sample@ https://www.precedenceresearch.com/sample/1808
Report Scope of the Blood Clot Retrieval Devices Market
| Report Coverage | Details |
| Market Size by 2030 | USD 4.5 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 14.79% |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Stroke, Device, Application, End User, Geography |
A recent
report provides crucial insights along with application based and forecast
information in the Global Blood clot retrieval devices Market. The report
provides a comprehensive analysis of key factors that are expected to drive the
growth of this market. This study also provides a detailed overview of the
opportunities along with the current trends observed in the Blood clot
retrieval devices market.
A
quantitative analysis of the industry is compiled for a period of 10 years in
order to assist players to grow in the market. Insights on specific revenue
figures generated are also given in the report, along with projected revenue at
the end of the forecast period.
Companies
and Manufacturers Covered
The study
covers key players operating in the market along with prime schemes and
strategies implemented by each player to hold high positions in the industry.
Such a tough vendor landscape provides a competitive outlook of the industry,
consequently existing as a key insight. These insights were thoroughly analysed
and prime business strategies and products that offer high revenue generation
capacities were identified. Key players of the global Blood clot retrieval
devices market are included as given below:
Blood clot retrieval devices Market Key Players
- AngioDynamics
- Terumo Co.
- Johnson and Johnson
- ECKOS Co.
- Bayer HealthCare LLC
- Boston Scientific Co.
- Argon Medical Devices
- Medtronic Plc
- Teleflex Incorporated
- Penumbra
Market Segments
- Ischemic Stroke (blood clot)
- Hemorrhagic Stroke (rupturing of arteries)
- Transient Ischemic Attack
By Device
- Mechanical Embolus Removal Devices
- Penumbra Blood Clot Retrieval Devices
- Stent Retrievers
- Aspiration Device
- Ultrasound Assisted Devices
By Application
- Coronary Arteries
- Peripheral Arteries
- Cerebral Arteries
By End User
- Hospitals
- Diagnostic Centers
- Clinics
- Ambulatory Surgical Centers
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global blood clot
retrieval devices market based on product, and region
- To provide detailed information regarding the major
factors influencing the growth of the market (drivers, opportunities, and
industry-specific challenges)
- To strategically analyze micromarkets1 with respect to
individual growth trends, future prospects, and contributions to the total
market
- To analyze opportunities in the market for stakeholders
and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to
four main regions—North America,
Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively
analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as
acquisitions, expansions, new product launches, and partnerships in the blood
clot retrieval devices market
Table of Content
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Blood Clot Retrieval Devices Market
5.1. COVID-19 Landscape: Blood Clot Retrieval Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Blood Clot Retrieval Devices Market, By Stroke
8.1. Blood Clot Retrieval Devices Market, by Stroke, 2022-2030
8.1.1. Ischemic Stroke (blood clot)
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Hemorrhagic Stroke (rupturing of arteries)
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Transient Ischemic Attack
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Blood Clot Retrieval Devices Market, By Devices
9.1. Blood Clot Retrieval Devices Market, by Devices, 2022-2030
9.1.1. Mechanical Embolus Removal Devices
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Penumbra Blood Clot Retrieval Devices
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Stent Retrievers
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Aspiration Device
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Ultrasound Assisted Devices
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Blood Clot Retrieval Devices Market, By Application
10.1. Blood Clot Retrieval Devices Market, by Application, 2022-2030
10.1.1. Coronary Arteries
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Peripheral Arteries
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Cerebral Arteries
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Blood Clot Retrieval Devices Market, By End User
11.1. Blood Clot Retrieval Devices Market, by End User, 2022-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Diagnostic Centers
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Clinics
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Ambulatory Surgical Centers
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Blood Clot Retrieval Devices Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.1.2. Market Revenue and Forecast, by Devices (2017-2030)
12.1.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Devices (2017-2030)
12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Devices (2017-2030)
12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.2.2. Market Revenue and Forecast, by Devices (2017-2030)
12.2.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Devices (2017-2030)
12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Devices (2017-2030)
12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Devices (2017-2030)
12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Devices (2017-2030)
12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.3.2. Market Revenue and Forecast, by Devices (2017-2030)
12.3.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Devices (2017-2030)
12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Devices (2017-2030)
12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Devices (2017-2030)
12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Devices (2017-2030)
12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.4.2. Market Revenue and Forecast, by Devices (2017-2030)
12.4.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Devices (2017-2030)
12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Devices (2017-2030)
12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Devices (2017-2030)
12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Devices (2017-2030)
12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.5.2. Market Revenue and Forecast, by Devices (2017-2030)
12.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Devices (2017-2030)
12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Stroke (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Devices (2017-2030)
12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
Chapter 13. Company Profiles
13.1. AngioDynamics
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Terumo Co.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Johnson and Johnson
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. ECKOS Co.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Bayer HealthCare LLC
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Boston Scientific Co.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Argon Medical Devices
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Medtronic Plc
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Teleflex Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Penumbra
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments